Key Points
- Insider Jeffrey Yu bought 142,857 OneMedNet shares at an average price of $0.63, spending approximately $90,000. The purchase increased his ownership by 1.63% to 8.92 million shares.
- OneMedNet’s stock opened at $0.67, with a market capitalization of about $39.7 million and a 52-week range of $0.49 to $4.22. The company recently reported a quarterly loss of $0.04 per share on $0.29 million in revenue.
- Analyst sentiment remains negative: One analyst rates the stock Sell, while ratings providers recently maintained or downgraded their bearish views.
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu purchased 142,857 shares of the firm's stock in a transaction dated Thursday, September 10th. The shares were bought at an average cost of $0.63 per share, for a total transaction of $89,999.91. Following the completion of the purchase, the insider directly owned 8,923,267 shares of the company's stock, valued at $5,621,658.21. The trade was a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Jeffrey Yu also recently made the following trade(s):
- On Tuesday, June 23rd, Jeffrey Yu bought 158,730 shares of OneMedNet stock. The stock was acquired at an average cost of $0.63 per share, for a total transaction of $99,999.90.
- On Tuesday, June 16th, Jeffrey Yu purchased 172,414 shares of OneMedNet stock. The shares were acquired at an average price of $0.58 per share, with a total value of $100,000.12.
OneMedNet Price Performance
ONMD opened at $0.67 on Tuesday. The company has a market cap of $39.72 million, a price-to-earnings ratio of -4.19 and a beta of 1.12. The firm has a 50 day simple moving average of $0.66 and a 200 day simple moving average of $0.75. OneMedNet Corporation has a fifty-two week low of $0.49 and a fifty-two week high of $4.22.
OneMedNet (NASDAQ:ONMD - Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $0.29 million for the quarter.
Analyst Upgrades and Downgrades
ONMD has been the subject of a number of analyst reports. Weiss Ratings raised OneMedNet from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Monday, August 24th. Wall Street Zen lowered OneMedNet from a "hold" rating to a "sell" rating in a research note on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of "Sell".
View Our Latest Analysis on OneMedNet
OneMedNet Company Profile
(
Get Free Report)
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
